Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial

Vaccine

Volumn 27, Issue 35, 2009, Pages 4834-4839

  Chiu, Susan S ^a   Chan, Kwok Hung ^a   Tu, Wenwei ^a   Lau, Yu Lung ^a   Peiris, J S Malik ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

Intradermal influenza vaccination; Young infants

Indexed keywords

INFLUENZA VACCINE; MATERNAL ANTIBODY;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DRUG SAFETY; DRUG TOLERABILITY; ECCHYMOSIS; ERYTHEMA; FEVER; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA VACCINATION; IRRITABILITY; MAJOR CLINICAL STUDY; MALAISE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SHIVERING; SIDE EFFECT; SKIN INDURATION;

ANTIBODIES, VIRAL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; VACCINES, INACTIVATED;

EID: 67650224009     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.066     Document Type: Article

References (24)

1. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342 (2000) 232-239
2. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., and Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000) 225-231
3. Chiu S.S., Lau Y.L., Chan K.H., Wong W.H.S., and Peiris J.S. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347 (2002) 2097-2103
4. Bhat N., Wrigth J.G., Broder K.R., Murray E.L., Greenberg M.E., Glover M.J., et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 353 (2005) 2559-2567
5. Louie J.K., Schechter R., Honarmand S., Guevara H.F., Shoemaker T.R., Madrigal N.Y., et al. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations. Pediatrics 117 (2006) e610-e618
6. Glezen W.P., Taber L.H., Frank A.L., Gruber W.C., and Piedra P.A. Influenza virus infections in infants. Pediatr Infect Dis J 16 (1997) 1065-1068
7. Groothuis J.R., Levin M.J., Rabalais G.P., Meiklejohn G., and Lauer B.A. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 87 (1991) 823-828
8. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Eng J Med 359 (2008) 1555-1563
9. Weller T.H., Cheever F.S., and Enders J.F. Immunologic reactions following the intradermal inoculation of influenza A and B vaccine. Proc Soc Exp Biol Med 67 (1948) 96-101
10. Quilligan Jr. J.J., Salgado P.F., and Alena B. Influenza vaccination in children. Am J Dis Child 101 (1961) 593-601
11. Klein M., and Huang N. The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes. J Pediatr 58 (1961) 312-314
12. McElroy J.T., and Szwed J.J. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine. N Eng J Med 281 (1969) 1076
13. Marks M.I., and Eller J.J. Intradermal influenza immunization. Experience with Hong Kong vaccine. Am Rev Respir Dis 103 (1971) 579-581
14. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 (2004) 2286-2294
15. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351 (2004) 2295-2301
16. Chiu S.S., Peiris J.S., Chan K.H., Wong W.H.S., and Lau Y.L. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 119 (2007) 1076-1082
17. Sugimura T., Ito Y., Tananari Y., Ozaki Y., Maeno Y., Yamaoko T., et al. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Vaccine 26 (2008) 2700-2705
18. Kangro H.O., Osman H.K., Lau Y.L., Heath R.B., Yeung C.Y., and Ng M.H. Seroprevalence of antibodies to human herpesvirus in England and Hong Kong. J Med Virol 43 (1994) 91-96
19. Chan K.H., Tam J.S.L., Peiris J.S.M., Seto W.H., and Ng M.H. Epstein-Barr virus (EBV) infection in infancy. J Clin Virol 21 (2001) 57-62
20. Halasa N.B., Gerber M.A., Chen Q., Wright P.F., and Edwards K.M. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 197 (2008) 1448-1454
21. Chen D., Burger M., Chu Q., Endres R., Zuleger C., Dean H., et al. Epidermal power immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res 103 (2004) 147-153
22. Glenn G.M., Kenney R.T., Ellingsworth L.R., Frech S.A., Hammond S.A., and Zoeteweij J.P. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines 2 (2003) 253-267
23. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., Karrasch J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 198 (2008) 650-658
24. Leroux-Roels I., Vets E., Freese R., Seiberling M., Weber F., Salamand C., et al. Seasonal influenza vaccine delivered by intradermal microinjection: A randomized controlled safety and immunogenicity trial in adults. Vaccine 26 (2008) 6614-6619